The dynamics of the decline of pharmaceutical drugs are precisely those of a gold mine. The fist-sized nuggets have all been found, the gravel and sand is getting more expensive to recover, and soon there will be nothing but dust. We may have reached peak pharma — and there is nowhere to go but down.

To read Drew’s article in full, click here to go to the Undark website